diabetesTariff appliesAnnex III — Jul 31 2026

Farxiga Tariff Rate & July 31, 2026 Deadline

Farxiga (Dapagliflozin) — manufactured by AstraZeneca in Sweden. Treats type 2 diabetes, heart failure. Typical US retail $610 per month.

Tariff breakdown

Applicable rate: 100% (Annex III)
Effective date: 2026-07-31 (98 days away)
Manufacturer: AstraZeneca
Country of origin: Sweden
Annex III?: Yes
Current monthly retail: $610

Projected monthly retail, by pass-through scenario

Scenario	Pass-through	New monthly retail	Annual increase
Conservative	30%	$793	+$2,196
Likely	50%	$915	+$3,660
Worst case	100%	$1,220	+$7,320

Scenarios based on historical brand-pharma cost-shock pass-through. Not a forecast.

HTS classification

HTS 3004.90.9299

Dapagliflozin tablets, retail packaging, HTS 3004.90. AstraZeneca manufactures Farxiga in Sweden — subject to the 100% tariff.

Source: USITC Harmonized Tariff Schedule, 2026 Revision 2 — hts.usitc.gov

Alternatives: generics, biosimilars & US-made options

Jardiance (empagliflozin, Boehringer Ingelheim)

therapeutic alternative

Same SGLT2-inhibitor class; Germany-made, also Annex III — tariff applies.

Steglatro (ertugliflozin, Merck)

therapeutic alternative

Third SGLT2 choice; Merck is Annex III.

Dapagliflozin generic (pending)

generic

No FDA-approved US generic for dapagliflozin as of 2026 Q2.

Always consult your prescriber before switching medications. Biosimilars and generics are not interchangeable in every state without physician approval.

FAQ: Farxiga and the 2026 tariff

Will my Farxiga prescription cost more after July 31, 2026?

Likely yes. Farxiga is manufactured in Sweden and is not exempt. Our conservative-case scenario assumes 30% pass-through (retail +$183/month), our likely-case 50% (+$305/month), and worst-case full pass-through (+$610/month).

Can I switch to a generic version of Dapagliflozin?

There are generic options listed above — their availability and interchangeability depend on FDA approval and state substitution rules. Confirm with your pharmacist before switching.

Is Farxiga on the Medicare negotiated-price list?

Yes — Farxiga is part of the Medicare drug price negotiation program. Negotiated prices are contractual but can interact with tariff-driven manufacturer responses.

Importing pharmaceuticals commercially?

This page covers consumer drug pricing. For business imports (including finished-dose pharmaceuticals), use the full US import tariff calculator with HTS classification and Section 301/232/122 breakdown.

Disclaimer: Informational estimates based on public list prices, the April 2, 2026 Proclamation text, and USITC HTS data. Not medical, legal, or financial advice.

Talk to your doctor, pharmacist, and insurer about your specific medication.